In the accompanying paper it has been established that patients with Hunter's syndrome tend to fall clearly into one of two groups depending upon the presence or absence of intellectual deterioration. This report examines those clinical features which distinguish each form of the disease. In addition a method is presented for predicting the ultimate disease course in a young isolated case.
Patients and methods
Of the 47 living patients ascertained, 31 were personally examined either in the family home or at a local hospital. The hospital records of the remaining 16 boys were available for review. Details of the 41 dead patients were obtained from hospital records or discussion with living relatives or both.
The following observations are based upon analysis of the disease course in 52 severely and 31 mildly affected patients. Cases 17 to 22 and 75, who were discussed in the previous paper, have been included with the mildly affected cases because there was no firm evidence of neurodegeneration in these patients.
Results

NATURAL HISTORY
The ages of onset The carpal tunnel syndrome has been noted in patients with mild Hunter's syndrome as early as 10 years of age.5 In this disorder the median nerve becomes constricted by thickening of the flexor retinaculum. The peripheral nerve itself is not exempt from abnormal storage, as shown by sural nerve biopsy in a 20-year-old man with proven Hunter's syndrome, which revealed multivacuolated endoneurial fibroblasts and perineurial cells with 'zebra bodies' in the Schwann cells.6 A unique sibship has been reported consisting of three brothers aged 35, 31, and 26 years, in whom the diagnosis of Hunter's syndrome was first suspected and subsequently proven after the demonstration of similar 'zebra bodies' in epineurial fibroblasts from sural nerve biopsy.7
Other factors which suggest that the nervous system is not entirely exempt from damage in the mild form of Hunter's syndrome include papilloedema, sensorineural deafness, and discrepancy in IQ subscores, noted both in this study and in others.8 9 One subject in this study demonstrated a slowly progressive quadriparesis similar to the myelopathy described by Ballenger et al'0 in a confirmed mild case aged 24 years. However, the extent and rate of central nervous system involvement in the severe form of the disorder permit easy separation of the mild and severe entities and the clinical correlates noted in this paper confirm their separate identity.
The data shown in fig 4 provide a means of predicting the ultimate disease severity in an isolated case based on age at onset. The provision of such information may enable both parents and health care professionals involved in the management of these children to be forewarned of, and therefore hopefully forearmed for, the many problems which lie ahead.
We are particularly indebted to the patients and their families for the co-operation received. Special thanks also go to Drs P F Benson and R Stephens for allowing us to study their patients, to Dr R Sanger for performing Xg blood group analyses, and to Action Research for the Crippled Child for financial support.
The following physicians kindly allowed us to visit patients under their care or provided clinical details: W A Arrowsmith, A W Blair, M Bobrow, A Bogdan, A R Boon, D P Brenton, E M Carr
